Nvidia, Amphenol, Lockheed Martin And A Health Care Stock On CNBC's 'Final Trades' - Lockheed Martin (NYSE:LMT), Amphenol (NYSE:APH)
Benzinga·2025-10-01 14:10

Company Highlights - NVIDIA Corporation reached a market capitalization of $4.5 trillion, becoming the first company to achieve this milestone, driven by advancements in artificial intelligence [2] - Lockheed Martin Corporation's stock gained approximately 10% over the month and is in positive territory for the year, following a $10.855 billion contract from the U.S. Navy for CH-53 K King Stallion helicopters [3] - Regeneron Pharmaceuticals received FDA approval for its drug Evkeeza, aimed at treating children with homozygous familial hypercholesterolemia [4] - Amphenol Corporation was maintained with a Buy rating by Goldman Sachs, with an increased price target from $124 to $139 [5] Stock Performance - NVIDIA shares increased by 2.6%, closing at $186.58 [7] - Lockheed Martin shares rose by 1.5%, settling at $499.21 [7] - Regeneron Pharmaceuticals shares saw a slight increase of 0.3%, closing at $562.27 [7] - Amphenol shares gained 2.3%, settling at $123.75 [7]